U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine
Status: Currently in Shortage
»Date first posted: 02/22/2012
»Therapeutic Categories: Anesthesia; Pediatric

Expand all

Fresenius Kabi USA, LLC (Revised 08/12/2022)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Xylocaine w/EPI 10 mL, 100 mg MDV (NDC 63323-0482-17) Backordered. Next release August 2022. Manufacturing delay
Xylocaine w/EPI 10 mL, 100mg SDV, MPF (NDC 63323-0487-17) Backordered. Next release August 2022. Manufacturing delay
Xylocaine w/EPI 10 mL, 150 mg, SDV, MPF (NDC 63323-0488-17) Backordered. Next release not available at this time. Manufacturing delay
Xylocaine w/EPI 10 mL, 200 mg, SDV, MPF (NDC 63323-0489-17) Backordered. Next release September 2022. Manufacturing delay

Hospira, Inc. (Revised 07/01/2022)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.5% w/EPI 1:100,000; 1.8 mL Carpule (NDC 00409-0996-01) Discontinued Discontinuation of the manufacture of the drug
2.5 g/50 mL (0.5%; 1:200,000); Multiple Dose Glass Fliptop Vial (NDC 00409-3177-01) Next Delivery: July 2022; Estimated Recovery: December 2022 Demand increase for the drug
200 mg/20 mL (1%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 00409-3178-01) Next Delivery: June 2022; Estimated Recovery: March 2023 Demand increase for the drug
300 mg/30 mL (1%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 00409-3178-02) Next Delivery: July 2022; Estimated Recovery: March 2023 Demand increase for the drug
500 mg/50 mL (1%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3178-03) Next Delivery: June 2022; Estimated Recovery: March 2023 Demand increase for the drug
75 mg/5 mL (1.5%; 1:200,000); Glass Ampul (NDC 0409-1209-01) Next Delivery and Estimated Recovery: August 2022 Demand increase for the drug
450 mg/30 mL (1.5%; 1:200,000); Single Dose Glass Fliptop Vial (NDC 0409-3181-01) Next Delivery: July 2022; Estimated Recovery: August 2022 Demand increase for the drug
400 mg/20 mL (2%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3182-01) Limited Supply Available. Next Delivery: June 2022; Estimated Recovery: January 2023 Demand increase for the drug
600 mg/30 mL (2%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3182-02) Next Delivery and Estimated Recovery: March 2023 Demand increase for the drug
1 g/50 mL (2%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3182-03) Next Delivery: August 2022; Estimated Recovery: March 2023 Demand increase for the drug
400 mg/20 mL (2%; 1:200,000); Single Dose Glass Fliptop Vial (NDC 0409-3183-01) Next Delivery: June 2022; Estimated Recovery: October 2022 Demand increase for the drug
2% w/EPI 1:50,000; 1.8mL syringe (NDC 00409-7263-01) Discontinued Discontinuation of the manufacture of the drug
Back to Top